Improving Expression of scFv Fragments by Co-expression of Periplasmic Chaperones
Today, recombinant protein expression in E. coli is usually considered a routine technology. Nonetheless, problems with soluble expression, rooted in protein aggregation competing with folding, are still frequently encountered. Many antibody fragments from natural sources are aggregation-prone during folding. Antibodies and their derivatives need to have disulfide bonds for functional expression, and this normally mandates their export to the oxidizing periplasm, and this oxidative folding may compound the problem. For this reason, the co-expression of chaperones assisting in the folding process of the protein of interest has proven to be a useful approach. We describe here both a series of chaperone co-expression vectors for co-transformation with the antibody expression plasmid of interest, as well as the use of the plasmids pHB110 and pHB610, which carry expression cassettes for scFv fragments and specific chaperones, previously found to be useful for antibody fragments, in the same vector. These systems can also be used in phage display (see Chap. 2), as well as in the production of antibody fusion proteins, including bivalent miniantibodies (see Chap. 43) and other constructs. We discuss the procedure of small-scale expression for testing the effect of the co-expressed chaperones, and give details on large-scale expression, including a detailed description on a rapid two-column purification of the scFv fragment.
Phosphate buffered saline
Single-chain Fv fragment
Enzyme-linked Immunosorbent Assay
Super broth media
This protocol has evolved over the years, and heavily relies on the research and the original versions developed by Hendrick Bothmann.
- De Cock H, Schäfer U, Potgeter M, Demel R, Müller M, Tommassen J (1999) Affinity of the periplasmic chaperone Skp of Escherichia coli for phospholipids, lipopolysaccharides and non-native outer membrane proteins. Role of Skp in the biogenesis of outer membrane protein. Eur J Biochem 259:96–103PubMedCrossRefGoogle Scholar
- Hu X, O'Hara L, White S, Magner E, Kane M, Wall JG (2007) Optimisation of production of a domoic acid-binding scFv antibody fragment in Escherichia coli using molecular chaperones and functional immobilisation on a mesoporous silicate support. Protein Expr Purif 52:194–201PubMedCrossRefGoogle Scholar
- Kügler M, Stein C, Schwenkert M, Saul D, Vockentanz L, Huber T, Wetzel SK, Scholz O, Plückthun A, Honegger A, Fey GH (2009) Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework. Protein Eng Des Sel 22:135–147PubMedCrossRefGoogle Scholar
- Plückthun A, Krebber A, Krebber C, Horn U, Knüpfer U, Wenderoth R, Nieba L, Proba K, Riesenberg D (1996) Producing antibodies in Eschericia coli: Fom PCR to fermentation. In: McCafferty J, Hoogenboom H (eds) Antibody engineering: a practical approach. IRL press, Oxford, pp 203–252Google Scholar
- Sambrook J, Russell D (2001) Molecular cloning. A laboratory manual, 3rd edn. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press 2001Google Scholar
- Thorpe SJ, Kerr MA (1994) Common immunological techniques: ELISA, blotting, immunohistochemistry and immunocytochemistry. In: Kerr M, Thorpe R (eds) Immunochemistry. Oxford, Labfax, BIOS Scientific Publishers Limited, pp 175–209Google Scholar
- Willuda J, Honegger A, Waibel R, Schubiger PA, Stahel R, Zangemeister-Wittke U, Plückthun A (1999) High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res 59:5758–5767PubMedGoogle Scholar